文献速递其他结缔组织病

NCF1低功能变异通过促进转换记忆B细胞募集和长寿命浆细胞分化加重干燥综合征唾液腺免疫病理

Human hypofunctional NCF1 variant aggravates salivary gland immunopathology in Sjögren's disease by promoting switched memory B-cell recruitment and long-lived plasma cell differentiation.
PubMed 文献 · Ann Rheum Dis · 2026-04-18

该研究评估了系统性红斑狼疮致病性低功能变异NCF1-p.Arg90His在干燥综合征(SjD)中的作用。病例对照队列显示NCF1-H90等位基因与SjD风险增加相关(Pmeta=1.15E-55,OR=2.58),在SSA+SjD中关联更强。机制上,H90携带者转换记忆B细胞剂量依赖性减少,可能被成纤维细胞募集至小唾液腺并分化为长寿命IgG+浆细胞,导致血清SSA+IgG升高和疾病更严重。

要点

  • NCF1-H90等位基因与SjD风险增加相关,SSA+患者中关联更强。
  • H90纯合子患者基线C4更低、唇腺活检评分及ESSDAI/ESSPRI更高,随访期疾病活动持续升高且生存率降低。
  • H90纯合子患者对贝利尤单抗治疗反应更佳。

核心结论

  • NCF1低活性通过驱动转换记忆B细胞转运和IgG+浆细胞分化增加严重SSA+SjD风险,揭示了SSA+SjD的可靶向通路。

研究设计与样本

  • 病例对照队列评估NCF1-H90与SjD的关联;对SSA+SjD患者的外周血单个核细胞(PBMC)和小唾液腺(MSG)分别采用飞行时间流式细胞术和单细胞RNA测序分析;纵向观察队列评估基线H90纯合子患者的临床指标;回顾性贝利尤单抗治疗SSA+女性队列评估治疗反应。

主要发现

  • NCF1-H90等位基因与中国和欧洲裔美国人SjD风险增加相关(Pmeta=1.15E-55,OR=2.58),SSA+SjD中关联更强(中国OR=3.37,欧洲裔美国人OR=2.60)。
  • 纵向观察队列中,基线H90纯合子SjD患者补体C4水平更低,唇腺活检评分、ESSDAI和ESSPRI评分更高,随访年间ESSDAI和ESSPRI持续升高且生存率降低。
  • SjD PBMC中H90拷贝数0、1、2呈现转换记忆B细胞剂量依赖性减少,该细胞可能被成纤维细胞募集至MSG并分化为长寿命IgG+浆细胞,导致血清SSA+IgG升高和疾病更严重。
  • 回顾性贝利尤单抗治疗的SSA+女性队列中,H90纯合子患者ESSDAI、C4水平和血清SSA+IgG水平改善显著更佳。

关键数值与推荐

  • NCF1-H90与SjD关联的荟萃分析Pmeta=1.15E-55,OR=2.58;SSA+SjD中中国人群OR=3.37,欧洲裔美国人群OR=2.60。

临床怎么用

  • NCF1-H90可作为预测SSA+SjD患者对B细胞靶向治疗(如贝利尤单抗)反应增强的生物标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We assessed the role of a systemic lupus erythematosus causal, hypofunctional variant, neutrophil cytosolic factor 1 (NCF1)-p.Arg90His (p.R90H) substitution, in Sjögren's disease (SjD). METHODS: Association between NCF1-H90 and SjD was assessed in case-control cohorts. Peripheral blood mononuclear cells (PBMCs) and minor salivary gland (MSG) from patients with Sjögren's Syndrome type A antigen (SSA)+ SjD were assessed using cytometry by time-of-flight and single-cell RNA sequencing, respectively. RESULTS: The NCF1-H90 allele was associated with increased risk for SjD in Chinese and European Americans (Pmeta = 1.15E-55, odds ratio [OR] = 2.58), exhibiting a more robust association in patients with SSA+ SjD (OR = 3.37 in Chinese and OR = 2.60 in European Americans). In a longitudinal observational cohort, patients with homozygous H90 SjD at baseline had lower levels of complement C4 and higher scores on labial salivary gland biopsy, European Alliance of Associations for Rheumatology (EULAR) Sjögren's Syndrome Disease Activity Index (ESSDAI), and EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI). These patients with H90 SjD sustained elevated ESSDAI and ESSPRI scores during follow-up years with decreased survival. The 0, 1, and 2 copies of H90 carriage in SjD PBMCs exhibited dose-dependent decreases in switched memory B cells, which might be recruited by fibroblasts into MSG, and further differentiated into long-lived Immunoglobulin G (IgG+) plasma cells, resulting in elevated serum SSA+ IgG levels and greater disease severity. In a retrospective belimumab-treated SSA+ female cohort, homozygous H90 patients showed significantly greater improvement in ESSDAI, C4 levels, and serum SSA+ IgG levels, supporting the role of NCF1-H90 as a predictive biomarker for enhanced response to B-cell-targeted therapy. CONCLUSIONS: Low NCF1 activity increases the risk of severe SSA+ SjD by driving switched memory B-cell trafficking and IgG+ plasma cell differentiation, revealing targetable pathways in SSA+ SjD.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Yuan X, Qin X, Wu X, et al. Human hypofunctional NCF1 variant aggravates salivary gland immunopathology in Sjögren's disease by promoting switched memory B-cell recruitment and long-lived plasma cell differentiation. Ann Rheum Dis. 2026. PMID: 42000201. doi:10.1016/j.ard.2026.03.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。